Related Experiment Video
Updated: Jun 14, 2025

06:15
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
1.1K
Basosquamous Carcinoma: A Rare Entity With an Atypical Presentation
1Dermatology Unit, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences, Casablanca, MAR.
Cureus
|September 6, 2024
Summary
Basosquamous carcinoma (BSC), a rare cancer sharing traits of basal cell and squamous cell carcinomas, was observed on a fingertip. Surgical resection was the successful management for this unique case.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Basosquamous carcinoma (BSC) is an uncommon neoplasm, nosologically positioned between basal cell carcinoma and squamous cell carcinoma.
- BSC exhibits histological features of both basal cell carcinoma and squamous cell carcinoma.
- The rarity of BSC necessitates case reports to understand its clinical behavior and management.
Observation:
- This report details a rare case of basosquamous carcinoma (BSC) presenting with unusual topography on the pulp of the left fifth finger.
- Clinical presentation and diagnostic workup were performed for the observed BSC.
- Histological examination was crucial in confirming the diagnosis of basosquamous carcinoma.
Findings:
- Histological examination confirmed the diagnosis of basosquamous carcinoma.
- Staging investigations, including locoregional and general extension studies, were negative, indicating no distant metastasis.
- The patient's condition was managed effectively through surgical resection.
Implications:
- This case highlights the importance of considering rare diagnoses like basosquamous carcinoma, even with atypical presentations.
- Surgical resection appears to be an effective management strategy for localized basosquamous carcinoma.
- Further case reports are needed to build a comprehensive understanding of basosquamous carcinoma epidemiology and treatment outcomes.
Related Concept Videos
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K

